IRD vs LIEN
Comparison between Ocuphire Pharma Inc (IRD, Company) and Chicago Atlantic BDC Inc (LIEN, Company).
IRD is from the Healthcare sector, while LIEN is from the Financial Services sector.
IRD vs LIEN - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
IRD vs LIEN - Historical Returns
Returns include dividend reinvestment.
IRD vs LIEN - Annual Returns (2005 - 2026)
Returns include dividend reinvestment.
| Year | IRD | LIEN |
|---|---|---|
| 2026 | +45.28% | -2.65% |
| 2025 | +59.52% | -6.78% |
| 2024 | -61.24% | +58.26% |
| 2023 | -14.25% | +2.77% |
| 2022 | -12.84% | -30.00% |
| 2021 | -46.71% | N/A |
| 2020 | -19.28% | N/A |
| 2019 | -83.42% | N/A |
| 2018 | -55.71% | N/A |
| 2017 | +39.21% | N/A |
| 2016 | -58.34% | N/A |
| 2015 | -50.50% | N/A |
| 2014 | +36.13% | N/A |
| 2013 | +59.67% | N/A |
| 2012 | -22.50% | N/A |
| 2011 | -66.73% | N/A |
| 2010 | +69.70% | N/A |
| 2009 | -20.00% | N/A |
| 2008 | -60.44% | N/A |
| 2007 | +66.59% | N/A |
| 2006 | -32.50% | N/A |
| 2005 | -33.33% | N/A |
IRD vs LIEN Drawdown Comparison
The maximum drawdown for IRD was -99.98%, occurring on Apr 11, 2025. This drawdown has not yet recovered.
The maximum drawdown for LIEN was -46.91%, occurring on Jul 25, 2023. Recovery took 570 trading sessions.
The current IRD drawdown is -99.89%. The current LIEN drawdown is -11.35%.
| Rank | IRD | LIEN |
|---|---|---|
| #1 | -99.98% May 27, 2008 - Apr 11, 2025 | -46.91% Mar 11, 2022 - Jun 18, 2024 |
| #2 | -78.00% Aug 29, 2006 - May 27, 2008 | -22.38% Oct 15, 2024 - Jun 20, 2025 |
| #3 | -75.00% Aug 25, 2005 - Aug 29, 2006 | -10.31% Jun 18, 2024 - Oct 4, 2024 |
| #4 | -23.08% Jun 22, 2005 - Jul 27, 2005 | -4.64% Feb 11, 2022 - Mar 11, 2022 |
| #5 | -16.67% May 23, 2005 - Jun 22, 2005 | -0.70% Oct 10, 2024 - Oct 14, 2024 |
| #6 | N/A | -0.25% Feb 4, 2022 - Feb 10, 2022 |
Correlation
Correlation between IRD and LIEN is -0.46 which considered as a weak negative correlation - the stocks show a slight tendency to move in opposite directions.
Select Stocks to Compare
More Comparisons
Compare with similar stocks